Insider Trading activities of Targacept Inc insiders.

Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Targacept Inc since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Targacept Inc since year 2005. Table 2 shows the detailed insider transactions of Targacept Inc since 2005. The reporting company's ticker symbol is CBIO. The reporting company's CIK number is 1124105.
The total value of stock buying since 2005 is $37,918,654.
The total value of stock sales since 2005 is $50,723,482.
The total value of stock option exercises since 2005 is $6,485,737.


Go to page:  1   2 
Table 1. Monthly summaries of insider stock purchases, sales, and option exercises for Targacept Inc (CBIO).
Trading Period Insider Buying Insider Sales Option Exercises
year-month Shares Value Shares Value Shares Value
2015-12 19,000 $38,149 0 $0 0 $0
2013-12 0 $0 18,000 $96,153 15,000 $51,525
2013-11 0 $0 15,999 $82,602 0 $0
2013-05 6,000 $30,534 0 $0 0 $0
2013-03 20,000 $88,580 0 $0 0 $0
2012-11 1,450,341 $5,889,484 0 $0 0 $0
2012-10 52,000 $210,912 0 $0 0 $0
2012-07 0 $0 0 $0 4,333 $324
2012-06 7,500 $31,192 0 $0 0 $0
2012-05 0 $0 0 $0 15,938 $46,698
2012-02 0 $0 0 $0 798 $4,069
2011-07 0 $0 2,500 $52,550 2,500 $23,175
2011-06 0 $0 30,875 $672,982 30,875 $167,496
2011-05 0 $0 61,100 $1,458,475 59,100 $473,070
2011-04 0 $0 2,500 $66,500 2,500 $23,175
2011-03 0 $0 36,455 $1,086,070 36,455 $229,241
2011-02 0 $0 32,136 $875,125 32,136 $115,065
2011-01 0 $0 90,647 $2,459,605 90,647 $433,442
2010-12 0 $0 99,641 $2,454,682 99,641 $436,082
2010-11 0 $0 65,770 $1,499,038 65,770 $406,512
2010-10 0 $0 12,600 $310,846 12,600 $36,918
2010-08 0 $0 6,000 $133,794 6,000 $34,140
2010-07 0 $0 12,000 $250,448 12,000 $68,279
2010-05 0 $0 67,766 $1,626,464 54,571 $326,736
2010-04 0 $0 135,381 $3,207,376 135,381 $542,549
2010-03 0 $0 313 $6,075 313 $1,596
2010-02 0 $0 15,000 $298,815 15,000 $122,775
2010-01 0 $0 80,843 $1,660,394 73,108 $302,155
2009-12 0 $0 487,442 $10,686,059 417,923 $1,473,310
2009-10 0 $0 785,561 $18,193,941 147,161 $548,173
2009-09 0 $0 53,100 $834,136 53,100 $92,923
2009-08 0 $0 92,806 $1,256,706 94,906 $170,085
2009-07 35,216 $107,078 101,413 $1,061,232 101,413 $287,460
2009-03 7,500 $22,725 0 $0 0 $0
2008-08 0 $0 34,400 $348,309 26,597 $46,543
2008-07 0 $0 5,000 $45,105 0 $0
2007-08 0 $0 0 $0 3,333 $249
2007-05 0 $0 0 $0 5,333 $399
2007-03 0 $0 0 $0 1,000 $75
2007-02 0 $0 0 $0 10,000 $750
2006-11 0 $0 0 $0 11,856 $20,748
2006-04 3,500,000 $31,500,000 0 $0 0 $0

Table 2. Detailed insider stock purchases, sales, and option exercises of Targacept Inc insiders (CBIO)
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2015-12-17 Payne Fletcher (Chief Financial Officer) Buy 10,000 2.00 20,000
2015-12-17 Hill Stephen A (Director) Buy 5,000 2.03 10,149
2015-12-17 Usman Nassim (President & CEO) Buy 4,000 2.00 8,000
2013-12-05 Sandell Scott D (10% Owner) Sale 1,000 5.13 5,131
2013-12-05 Barrett M James (10% Owner) Sale 1,000 5.13 5,131
2013-12-05 Barris Peter J (10% Owner) Sale 1,000 5.13 5,131
2013-12-03 Barrett M James (10% Owner) Sale 15,000 5.38 80,760
2013-12-03 Barrett M James (10% Owner) Option Ex 15,000 3.44 51,525
2013-11-21 Sandell Scott D (10% Owner) Sale 5,333 5.16 27,534
2013-11-21 Barrett M James (10% Owner) Sale 5,333 5.16 27,534
2013-11-21 Barris Peter J (10% Owner) Sale 5,333 5.16 27,534
2013-05-10 Brown Julia R Buy 6,000 5.09 30,534
2013-03-11 Hill Stephen A (President and CEO) Buy 10,000 4.38 43,780
2013-03-08 Hill Stephen A (President and CEO) Buy 10,000 4.48 44,800
2012-11-16 Bvf Investments Llc (Other) Buy 73,500 5.11 375,438
2012-11-14 Bvf Investments Llc (Other) Buy 1,216,712 4.00 4,866,848
2012-11-08 Lampert Mark N (10% Owner) Buy 49,329 4.01 197,661
2012-11-07 Lampert Mark N (10% Owner) Buy 23,100 4.08 94,271
2012-11-02 Lampert Mark N (10% Owner) Buy 57,600 4.05 233,452
2012-11-01 Lampert Mark N (10% Owner) Buy 30,100 4.05 121,814
2012-10-31 Lampert Mark N (10% Owner) Buy 52,000 4.06 210,912
2012-07-31 Burrill Steven Option Ex 4,333 .08 324
2012-06-08 Richard John P Buy 7,500 4.16 31,192
2012-05-18 Bencherif Merouane (SVP, Preclinical Research) Option Ex 15,938 2.93 46,698
2012-02-14 Debethizy J Donald (President and CEO) Option Ex 798 5.10 4,069
2011-07-01 Richard John P Sale 2,500 21.02 52,550
2011-07-01 Richard John P Option Ex 2,500 9.27 23,175
2011-06-07 Musso Alan A (SVP, CFO & Treasurer) Sale 30,875 21.80 672,982
2011-06-07 Musso Alan A (SVP, CFO & Treasurer) Option Ex 30,875 5.42 167,496
2011-05-13 Brown Julia R Sale 9,100 23.38 212,785
2011-05-13 Brown Julia R Option Ex 9,100 8.70 79,170
2011-05-11 Burrill Steven Sale 33,052 23.88 789,347
2011-05-11 Burrill Steven Option Ex 33,052 7.11 235,098
2011-05-10 Burrill Steven Sale 18,948 24.08 456,343
2011-05-10 Burrill Steven Option Ex 16,948 9.37 158,802
2011-04-01 Richard John P Sale 2,500 26.60 66,500
2011-04-01 Richard John P Option Ex 2,500 9.27 23,175
2011-03-31 Caldwell William S (SVP - Drug Discovery and Dev.) Sale 2,655 26.37 70,012
2011-03-31 Caldwell William S (SVP - Drug Discovery and Dev.) Option Ex 2,655 2.93 7,779
2011-03-09 Hodges Mauri K (VP Fin + Corp Sys & Controller) Sale 1,500 30.00 45,000
2011-03-09 Hodges Mauri K (VP Fin + Corp Sys & Controller) Option Ex 1,500 5.55 8,325
2011-03-07 Hodges Mauri K (VP Fin + Corp Sys & Controller) Sale 500 30.00 15,001
2011-03-07 Hodges Mauri K (VP Fin + Corp Sys & Controller) Option Ex 500 5.55 2,775
2011-03-03 Hodges Mauri K (VP Fin + Corp Sys & Controller) Sale 5,030 30.00 150,900
2011-03-03 Hodges Mauri K (VP Fin + Corp Sys & Controller) Option Ex 5,030 5.55 27,916
2011-03-02 Hodges Mauri K (VP Fin + Corp Sys & Controller) Sale 200 30.00 6,000
2011-03-02 Hodges Mauri K (VP Fin + Corp Sys & Controller) Option Ex 200 5.55 1,110
2011-03-01 Hicks Karen A (VP Human Resources) Sale 1,243 30.00 37,290
2011-03-01 Hicks Karen A (VP Human Resources) Option Ex 1,243 8.42 10,459
2011-03-01 Hodges Mauri K (VP Fin + Corp Sys & Controller) Sale 12,703 30.16 383,147
2011-03-01 Hodges Mauri K (VP Fin + Corp Sys & Controller) Option Ex 12,703 5.55 70,501
2011-03-01 Brennan Jeffrey P (SVP - Bus. & Commercial Dev.) Sale 1,264 30.00 37,920
2011-03-01 Brennan Jeffrey P (SVP - Bus. & Commercial Dev.) Option Ex 1,264 2.93 3,703
2011-03-01 Caldwell William S (SVP - Drug Discovery and Dev.) Sale 11,360 30.00 340,800
2011-03-01 Caldwell William S (SVP - Drug Discovery and Dev.) Option Ex 11,360 8.51 96,673
2011-02-28 Caldwell William S (SVP - Drug Discovery and Dev.) Sale 15,481 28.00 433,468
2011-02-28 Caldwell William S (SVP - Drug Discovery and Dev.) Option Ex 15,481 5.55 85,919
2011-02-16 Caldwell William S (SVP - Drug Discovery and Dev.) Sale 16,655 26.52 441,657
2011-02-16 Caldwell William S (SVP - Drug Discovery and Dev.) Option Ex 16,655 1.75 29,146
2011-01-19 Richard John P Sale 5,000 27.11 135,540
2011-01-19 Richard John P Option Ex 5,000 2.71 13,550
2011-01-19 Bencherif Merouane (SVP, Preclinical Research) Sale 30,203 27.09 818,259
2011-01-19 Bencherif Merouane (SVP, Preclinical Research) Option Ex 30,203 3.65 110,240
2011-01-18 Richard John P Sale 2,500 27.38 68,440
2011-01-18 Richard John P Option Ex 2,500 2.71 6,775
2011-01-18 Bencherif Merouane (SVP, Preclinical Research) Sale 22,800 27.17 619,476
2011-01-18 Bencherif Merouane (SVP, Preclinical Research) Option Ex 22,800 5.55 126,540
2011-01-14 Hicks Karen A (VP Human Resources) Sale 1,719 27.50 47,272
2011-01-14 Hicks Karen A (VP Human Resources) Option Ex 1,719 2.93 5,036
2011-01-13 Hicks Karen A (VP Human Resources) Sale 3,369 27.24 91,761
2011-01-13 Hicks Karen A (VP Human Resources) Option Ex 3,369 2.93 9,871
2011-01-12 Hicks Karen A (VP Human Resources) Sale 11,231 27.18 305,292
2011-01-12 Hicks Karen A (VP Human Resources) Option Ex 11,231 5.72 64,241
2011-01-11 Hicks Karen A (VP Human Resources) Sale 13,825 27.02 373,565
2011-01-11 Hicks Karen A (VP Human Resources) Option Ex 13,825 7.03 97,189
2010-12-22 Musso Alan A (SVP, CFO & Treasurer) Sale 4,881 26.47 129,200
2010-12-22 Musso Alan A (SVP, CFO & Treasurer) Option Ex 4,881 5.10 24,893
2010-12-21 Musso Alan A (SVP, CFO & Treasurer) Sale 15,535 26.61 413,386
2010-12-21 Musso Alan A (SVP, CFO & Treasurer) Option Ex 15,535 5.10 79,228
2010-12-20 Dunbar Geoffrey C (SVP, Clin. Dev. & Reg. Affairs) Sale 8,882 26.02 231,118
2010-12-20 Dunbar Geoffrey C (SVP, Clin. Dev. & Reg. Affairs) Option Ex 8,882 1.75 15,543
2010-12-17 Dunbar Geoffrey C (SVP, Clin. Dev. & Reg. Affairs) Sale 2,100 26.08 54,765
2010-12-17 Dunbar Geoffrey C (SVP, Clin. Dev. & Reg. Affairs) Option Ex 2,100 1.75 3,675
2010-12-16 Hodges Mauri K (VP Fin + Corp Sys & Controller) Sale 2,700 25.24 68,142
2010-12-16 Hodges Mauri K (VP Fin + Corp Sys & Controller) Option Ex 2,700 8.51 22,977
2010-12-16 Dunbar Geoffrey C (SVP, Clin. Dev. & Reg. Affairs) Sale 200 25.15 5,030
2010-12-16 Dunbar Geoffrey C (SVP, Clin. Dev. & Reg. Affairs) Option Ex 200 1.75 350
2010-12-13 Brennan Jeffrey P (SVP - Bus. & Commercial Dev.) Sale 10,000 23.86 238,550
2010-12-13 Brennan Jeffrey P (SVP - Bus. & Commercial Dev.) Option Ex 10,000 2.93 29,300
2010-12-13 Caldwell William S (SVP - Drug Discovery and Dev.) Sale 12,000 23.95 287,376
2010-12-13 Caldwell William S (SVP - Drug Discovery and Dev.) Option Ex 12,000 1.75 21,000
2010-12-10 Bencherif Merouane (SVP, Preclinical Research) Sale 32,093 24.05 771,965
2010-12-10 Bencherif Merouane (SVP, Preclinical Research) Option Ex 32,093 5.66 181,742
2010-12-08 Dunbar Geoffrey C (SVP, Clin. Dev. & Reg. Affairs) Sale 11,250 22.68 255,150
2010-12-08 Dunbar Geoffrey C (SVP, Clin. Dev. & Reg. Affairs) Option Ex 11,250 5.10 57,374
2010-11-17 Blixt Charles A Sale 5,500 21.76 119,663
2010-11-17 Blixt Charles A Option Ex 5,500 9.27 50,985
2010-11-17 Skaletsky Mark B Sale 29,500 22.00 649,000
2010-11-17 Skaletsky Mark B Option Ex 29,500 6.04 178,180
2010-11-16 Blixt Charles A Sale 9,500 21.80 207,071
2010-11-16 Blixt Charles A Option Ex 9,500 8.18 77,757
2010-11-16 Skaletsky Mark B Sale 3,000 21.76 65,295
2010-11-16 Skaletsky Mark B Option Ex 3,000 2.71 8,130
2010-11-05 Dunbar Geoffrey C (SVP, Clin. Dev. & Reg. Affairs) Sale 700 25.02 17,511
2010-11-05 Dunbar Geoffrey C (SVP, Clin. Dev. & Reg. Affairs) Option Ex 700 1.75 1,225
2010-11-04 Hodges Mauri K (VP Fin + Corp Sys & Controller) Sale 7,800 25.08 195,608
2010-11-04 Hodges Mauri K (VP Fin + Corp Sys & Controller) Option Ex 7,800 8.51 66,378
2010-11-04 Dunbar Geoffrey C (SVP, Clin. Dev. & Reg. Affairs) Sale 7,784 25.07 195,137
2010-11-04 Dunbar Geoffrey C (SVP, Clin. Dev. & Reg. Affairs) Option Ex 7,784 1.75 13,622
2010-11-03 Hodges Mauri K (VP Fin + Corp Sys & Controller) Sale 1,000 25.06 25,055
2010-11-03 Hodges Mauri K (VP Fin + Corp Sys & Controller) Option Ex 1,000 8.51 8,510
2010-11-03 Dunbar Geoffrey C (SVP, Clin. Dev. & Reg. Affairs) Sale 986 25.05 24,698
2010-11-03 Dunbar Geoffrey C (SVP, Clin. Dev. & Reg. Affairs) Option Ex 986 1.75 1,725
2010-10-28 Musso Alan A (SVP, CFO & Treasurer) Sale 1,500 24.60 36,900
2010-10-28 Musso Alan A (SVP, CFO & Treasurer) Option Ex 1,500 2.93 4,395
2010-10-26 Musso Alan A (SVP, CFO & Treasurer) Sale 2,000 24.65 49,296
2010-10-26 Musso Alan A (SVP, CFO & Treasurer) Option Ex 2,000 2.93 5,860
2010-10-25 Musso Alan A (SVP, CFO & Treasurer) Sale 8,500 24.69 209,890
2010-10-25 Musso Alan A (SVP, CFO & Treasurer) Option Ex 8,500 2.93 24,905
2010-10-22 Musso Alan A (SVP, CFO & Treasurer) Sale 600 24.60 14,760
2010-10-22 Musso Alan A (SVP, CFO & Treasurer) Option Ex 600 2.93 1,758
2010-08-02 Dunton Alan W Sale 6,000 22.30 133,794
2010-08-02 Dunton Alan W Option Ex 6,000 5.69 34,140
2010-07-26 Dunton Alan W Sale 2,864 21.12 60,476
2010-07-26 Dunton Alan W Option Ex 2,864 5.69 16,296
2010-07-23 Dunton Alan W Sale 2,336 21.00 49,063
2010-07-23 Dunton Alan W Option Ex 2,336 5.69 13,291
2010-07-15 Dunton Alan W Sale 6,800 20.72 140,909
2010-07-15 Dunton Alan W Option Ex 6,800 5.69 38,692
2010-05-21 Brown Julia R Sale 7,307 23.13 169,018
2010-05-21 Brown Julia R Option Ex 7,307 8.70 63,570
2010-05-20 Brown Julia R Sale 5,193 22.97 119,278
2010-05-20 Brown Julia R Option Ex 5,193 8.70 45,179
2010-05-18 Musso Alan A (SVP, CFO & Treasurer) Sale 3,424 24.70 84,572
2010-05-18 Musso Alan A (SVP, CFO & Treasurer) Option Ex 3,424 2.93 10,032
2010-05-17 Musso Alan A (SVP, CFO & Treasurer) Sale 8,782 24.40 214,315
2010-05-17 Musso Alan A (SVP, CFO & Treasurer) Option Ex 8,782 4.02 35,259
2010-05-14 Richard John P Sale 8,500 24.22 205,861
2010-05-14 Richard John P Option Ex 8,500 3.59 30,489
2010-05-13 Hicks Karen A (VP Human Resources) Sale 5,695 24.55 138,575
2010-05-13 Hicks Karen A (VP Human Resources) Option Ex 1,469 5.55 8,152
2010-05-13 Hodges Mauri K (VP Finance & Controller) Sale 1,402 25.00 35,050
2010-05-13 Hodges Mauri K (VP Finance & Controller) Option Ex 1,402 8.51 11,931
2010-05-13 Dunbar Geoffrey C (SVP, Clin. Dev. & Reg. Affairs) Sale 1,494 25.00 37,350
2010-05-13 Dunbar Geoffrey C (SVP, Clin. Dev. & Reg. Affairs) Option Ex 1,494 1.75 2,614
2010-05-12 Brown Julia R Sale 7,500 23.05 172,875
2010-05-03 Caldwell William S (SVP - Drug Discovery and Dev.) Sale 17,000 24.28 412,845
2010-05-03 Caldwell William S (SVP - Drug Discovery and Dev.) Option Ex 17,000 7.03 119,510
2010-04-30 Caldwell William S (SVP - Drug Discovery and Dev.) Sale 15,263 24.28 370,509
2010-04-30 Caldwell William S (SVP - Drug Discovery and Dev.) Option Ex 15,263 5.55 84,709
Go to page:  1   2 

Insider trading activities including stock purchases, stock sales, and option exercises of CBIO listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Targacept Inc (symbol CBIO, CIK number 1124105) see the Securities and Exchange Commission (SEC) website.